Evaluation of the aggressive variant prostate cancer molecular profile (AVPCm) in CLIA environments von Viscuse, Paul Vincent, Zhang, Miao, Rohra, Prih, Slack Tidwell, Rebecca, Pritchard, Colin C., Subudhi, Sumit Kumar, Pilié, Patrick Glen, Logothetis, Christopher, Corn, Paul Gettys, Aparicio, Ana

Volltext

Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC) von Pilié, Patrick Glen, Slack Tidwell, Rebecca, Viscuse, Paul Vincent, Subudhi, Sumit Kumar, Corn, Paul Gettys, Tu, Shi-Ming, Araujo, John C., Zurita, Amado J., Wang, Jennifer, Efstathiou, Eleni, Deinert, Jessica, Logothetis, Christopher, Thompson, Timothy C., Aparicio, Ana

Volltext

A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monito... von Hahn, Andrew Warren, Slack Tidwell, Rebecca, Thoman, Whittney, Abdulla, Amer, Koutroumpakis, Efstratios, Aparicio, Ana, Subudhi, Sumit Kumar, Siddiqui, Bilal Ahmed, Pilié, Patrick Glen, Zurita, Amado J., Corn, Paul Gettys, Laccetti, Andrew Leonard, Jana, Bagi RP, Basen-Engquist, Karen, Logothetis, Christopher

Volltext

Phase I/II study of the selective PI3Kβ inhibitor GSK2636771 in combination with pembrolizumab in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and PT... von Dumbrava, Ecaterina Elena, Burton, Elizabeth M., Subudhi, Sumit Kumar, Milton, Denai R., Aparicio, Ana, Yap, Timothy A., Naing, Aung, Corn, Paul Gettys, Pilié, Patrick Glen, Zurita, Amado J., Wang, Jennifer, Amaria, Rodabe Navroze, McQuade, Jennifer Leigh, Glitza, Isabella Claudia, Lazar, Alexander J., Meric-Bernstam, Funda, Logothetis, Christopher, Davies, Michael A., Hwu, Patrick, Tawbi, Hussein A.

Volltext

DynAMo: A dynamic allocation modular sequential trial of approved and promising therapies in men with metastatic CRPC von Viscuse, Paul Vincent, Tidwell, Rebecca, Liu, Jingjing, Guo, Shuai, Vundavilli, Haswanth, Zhang, Miao, Subudhi, Sumit Kumar, Zurita, Amado J., Corn, Paul Gettys, Tu, Shi-Ming, Araujo, John C., Wang, Jennifer, Efstathiou, Eleni, Wang, Jianbo, Pilié, Patrick Glen, Troncoso, Patricia, Zhang, Jianhua, Wang, Wenyi, Logothetis, Christopher, Aparicio, Ana

Volltext

Replication stress response deficiency (RSRD) and response to immune therapy in clear cell renal cell carcinoma (ccRCC) von Pilie, Patrick Glen, McGrail, Daniel James, Lin, Shiaw-Yih, Jonasch, Eric

Volltext

Third analysis of a randomized trial of finite abiraterone acetate (AA) plus LHRH agonist (LHRHa) versus LHRHa in biochemically recurrent, non-metastatic hormone-naïve prostate can... von Hahn, Andrew Warren, Wang, Xuemei, Efstathiou, Eleni, Hwang, Hyunsoo, Zurita, Amado J., Spetsieris, Nicholas, Boukovala, Myrto A, Wang, Jennifer, Araujo, John C., Pilie, Patrick Glen, Siddiqui, Bilal A., Subudhi, Sumit Kumar, Corn, Paul Gettys, Aparicio, Ana, Tu, Shi-Ming, Logothetis, Christopher

Volltext

Homologous repair deficiency in VHL -mutated clear cell renal cell carcinoma von Pilie, Patrick Glen, Zhou, Lijun, Peterson, Christine B, Peng, Yang, Peng, Guang, Jonasch, Eric

Volltext

Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy von Garmezy, Benjamin, Gheeya, Jinesh S., Thein, Kyaw Zin, Pilie, Patrick Glen, Wang, Wanlin, Rodon Ahnert, Jordi, Shaw, Kenna Rael, Meric-Bernstam, Funda, Yap, Timothy A

Volltext

Outcomes in men with metastatic castrate-resistant prostate cancer treated with early platinum-based chemotherapy following an unsatisfactory response to androgen receptor (AR) inh... von Viscuse, Paul Vincent, Zhang, Miao, Liu, Jingjing, Tidwell, Rebecca, Subudhi, Sumit Kumar, Zurita, Amado J., Corn, Paul G., Tu, Shi-Ming, Araujo, John C., Wang, Jennifer, Efstathiou, Eleni, Wang, Jianbo, Pilie, Patrick Glen, Troncoso, Patricia, Zhang, Jianhua, Logothetis, Christopher, Aparicio, Ana

Volltext

Functional biomarkers of homologous repair (HR) deficiency to guide novel DNA damage response targeted therapy in clear cell renal cell carcinoma (ccRCC) von Pilie, Patrick Glen, Peterson, Christine B, Peng, Yang, Zhou, Lijun, Yap, Timothy Anthony, Peng, Guang, Jonasch, Eric

Volltext

Real-world outcomes of genetic testing in a GU genetics clinic and evaluation of current guidelines von Pace, Annelise, Woodson, Ashley Henriksen, Slack-Tidwell, Rebecca, Daniels, Molly S., Pilie, Patrick Glen, Litton, Jennifer Keating, Hoskovec, Jennifer M., Jonasch, Eric

Volltext

Adiposity and response to androgen signaling inhibition (ASI) in men with metastatic castration-resistant prostate cancer (mCRPC) von Hahn, Andrew Warren, Tidwell, Rebecca, Surasi, Devaki Shilpa, Pilie, Patrick Glen, Frigo, Daniel, Subudhi, Sumit Kumar, Efstathiou, Eleni, Zurita, Amado J., Tu, Shi-Ming, Chapin, Brian Francis, Fogelman, David R., Starbuck, Michael W, Corn, Paul G., Aparicio, Ana, McQuade, Jennifer Leigh, Logothetis, Christopher

Volltext

Identifying functional loss of ATM gene in patients with advanced cancer von Pilie, Patrick Glen, Gheeya, Jinesh S., Kyewalabye, Keith, Goswamy, Rohit Vivek, Wani, Khalida M, Le, Hung, Campbell, Erick, Sanchez, Nora Sylvia, Yang, Dong, Garmezy, Benjamin, Ileana Dumbrava, Ecaterina Elena, Rodon Ahnert, Jordi, Heffernan, Timothy, Holla, Vijaykumar, Shaw, Kenna Rael, Meric-Bernstam, Funda, Lazar, Alexander J., Wang, Wei-Lien, Yap, Timothy A

Volltext

Linking the Aggressive Variant Prostate Cancer (AVPC) molecular signature (-ms) to androgen indifference in a prospective clinical trial von Viscuse, Paul Vincent, Zhang, Miao, Liu, Jingjing, Slack Tidwell, Rebecca, Subudhi, Sumit Kumar, Zurita, Amado J., Corn, Paul Gettys, Tu, Shi-Ming, Araujo, John C., Wang, Jennifer, Efstathiou, Eleni, Wang, Jianbo, Pilie, Patrick Glen, Troncoso, Patricia, Zhang, Jianhua, Logothetis, Christopher, Aparicio, Ana

Volltext

Genomic instability and DNA damage repair in clear cell renal cell carcinoma von Pilie, Patrick Glen, Zhou, Lijun, Tong, Pan, Matin, Surena F., Sircar, Kanishka, Tamboli, Pheroze, Karam, Jose A., Wood, Christopher G., Hoang, Anh, Jonasch, Eric

Volltext

Pilot study of dovitinib in patients with VHL disease von Pilie, Patrick Glen, Matin, Surena F., Woodson, Ashley Henriksen, Marcott, Valerie D., Bird, Shelly, Slack, Rebecca, Fuller, Greg, McCutcheon, Ian E., Jonasch, Eric

Volltext